Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements
Public ClinicalTrials.gov record NCT07294924. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PREDICT-ACC: Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements
Study identification
- NCT ID
- NCT07294924
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 14, 2025
- Primary completion
- Dec 14, 2026
- Completion
- Dec 14, 2026
- Last update posted
- Dec 18, 2025
2025 – 2026
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kernel | Los Angeles | California | 90232 | Not yet recruiting |
| Acacia Clinics | Sunnyvale | California | 94087 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Major Depressive Disorder (MDD) trials
Other public records listing Major Depressive Disorder (MDD). Sorted by last update posted; newest first. Not a recommendation.
- NCT07792252: REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness Not yet recruiting
- NCT07610473: A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression Recruiting
- NCT07734701: Pregnenolone Treatment for Alcohol Use Disorder and Major Depressive Disorder Not yet recruiting
- NCT07139834: Pattern Separation in Major Depressive Disorder Recruiting
- NCT07685964: Pregnenolone for Cannabis Use Disorder and Depression Not yet recruiting
- NCT07621237: A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07294924, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2025 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07294924 live on ClinicalTrials.gov.